Vaginal Bleeding Assessment and Management Algorithm
Initial Stabilization and Risk Stratification
Immediately assess hemodynamic status: check blood pressure, heart rate, and signs of hypovolemia (tachycardia >100 bpm, hypotension <90 mmHg systolic, altered mental status, or orthostatic changes). Patients with acute abnormal uterine bleeding require prompt evaluation for hemodynamic instability before proceeding with diagnostic workup 1.
Critical First Steps:
- Obtain vital signs to identify shock or impending cardiovascular collapse
- Establish IV access if patient shows signs of volume depletion
- Order immediate labs: CBC, type and screen, coagulation studies (PT/PTT), pregnancy test (β-hCG), and consider thyroid function
- Begin resuscitation with crystalloids if hemodynamically unstable
Pregnancy Status Determination
The single most important initial diagnostic step is determining pregnancy status with quantitative β-hCG, as this fundamentally changes the differential diagnosis and management pathway.
If Pregnant:
First Trimester Bleeding (≤13 weeks)
Approximately 25% of pregnant women experience first trimester bleeding with etiologies ranging from benign (normal intrauterine pregnancy with subchorionic hematoma) to life-threatening (ectopic pregnancy) 2.
Imaging approach:
- Transvaginal ultrasound is the primary and most appropriate initial imaging modality 2
- Transabdominal ultrasound can be complementary but transvaginal provides superior detail
- Avoid CT due to teratogenic radiation effects unless ultrasound and MRI are unavailable 2
Key differential diagnoses:
- Normal intrauterine pregnancy (IUP) ± subchorionic hematoma
- Nonviable IUP (missed abortion, incomplete abortion)
- Ectopic pregnancy (requires immediate identification)
- Gestational trophoblastic disease
Second/Third Trimester Bleeding (≥14 weeks)
Less common than first trimester but carries serious maternal and fetal risks 3.
Critical safety rule: Avoid digital pelvic examination until placenta previa, low-lying placenta, and vasa previa are excluded by ultrasound 3.
Imaging approach:
- Transabdominal ultrasound is the mainstay 3
- Transvaginal ultrasound is safe and accurate for placenta previa diagnosis and cervical evaluation 3
Key differential diagnoses:
- Placenta previa (most common diagnosis, ~1 in 200 deliveries) 3
- Placental abruption (~1% of pregnancies; ultrasound detects ≤50% of cases, but central abruption has worse outcomes than marginal) 3
- Vasa previa (rare: 1 in 2,500-5,000 deliveries) 3
- Uterine rupture (rare, mainly with prior cesarean or uterine surgery)
- Preterm labor with cervical bleeding
- Physiologic "bloody show" (term labor)
- Cervical causes: cervicitis, polyp
- Vaginal laceration
Note: Approximately 50% of second/third trimester bleeding cases have no identifiable cause 3.
If Not Pregnant:
PALM-COEIN Classification System
Categorize the bleeding pattern using the PALM-COEIN system to guide diagnosis and treatment 1:
Structural causes (PALM):
- Polyp
- Adenomyosis
- Leiomyoma (fibroids)
- Malignancy/hyperplasia
Non-structural causes (COEIN):
- Coagulopathy
- Ovulatory dysfunction
- Endometrial
- Iatrogenic (IUD, medications, anticoagulants)
- Not yet classified
Bleeding Pattern Categories:
- Irregular bleeding (unpredictable timing/amount)
- Heavy but regular bleeding (menorrhagia)
- Severe acute bleeding (requires immediate intervention)
- Contraceptive-associated bleeding
Medical Management (First-Line for Stable Patients)
Medical therapy should be the initial treatment for most hemodynamically stable patients 1.
Acute Bleeding Control Options:
For severe acute bleeding:
- Intravenous conjugated equine estrogen (25 mg IV every 4-6 hours for up to 24 hours) 1
- High-dose combined oral contraceptives (multi-dose regimen: one pill three times daily for 7 days) 1
- Oral progestins (high-dose regimens) 1
- Tranexamic acid (1300 mg orally three times daily during menstruation, or 10 mg/kg IV every 8 hours) 1, 4
For heavy menstrual bleeding (non-acute):
- NSAIDs (first 3 days of menstruation) as second-choice treatment 5
- Tranexamic acid (antifibrinolytic therapy) 5, 4
- Progestogens or sub-50 oral contraceptives for hormonal fluctuations 5
Treatment Selection Criteria:
Base decisions on:
- Patient's medical history
- Contraindications to estrogen (thromboembolism risk, cardiovascular disease, smoking >35 years)
- Contraindications to NSAIDs (renal disease, peptic ulcer)
- Severity of bleeding
- Desire for future fertility
Surgical Management
Consider surgical intervention for patients who are:
- Hemodynamically unstable despite resuscitation
- Unsuitable for medical management (contraindications)
- Failed to respond to medical management after appropriate trial 1
Surgical options depend on:
- Underlying pathology identified
- Patient's desire for future fertility
- Medical comorbidities
Postmenopausal Bleeding (Special Consideration)
Any postmenopausal bleeding requires exclusion of endometrial carcinoma 5.
Diagnostic approach:
- Cervical cytology (Pap smear)
- Transvaginal ultrasonography to measure endometrial thickness
- Endometrial thickness ≤4 mm is reassuring and patient can initially be observed 5
- Persistent or recurrent bleeding requires gynecology referral regardless of initial ultrasound findings 5
Bridging and Long-Term Maintenance
After acute bleeding control, transition to maintenance therapy to prevent recurrence 1, 6.
Bridging Phase (Post-Acute Control):
- Progestin-based regimens to maintain endometrial quiescence 6
- Continuous combined hormonal therapy (if no contraindications) 6
- Depot progestins 6
- Antifibrinolytic therapy during bleeding episodes 6
Long-Term Maintenance:
- Levonorgestrel-releasing intrauterine system (LNG-IUS) is definitive long-term option (insert after bleeding controlled and hemoglobin stabilized) 5, 6
- Combined oral contraceptives (if no contraindications)
- Cyclic or continuous progestins
- Tranexamic acid during menses
Common Pitfalls to Avoid
Performing digital pelvic exam in second/third trimester bleeding before ultrasound - can precipitate catastrophic hemorrhage with placenta previa 3
Failing to obtain pregnancy test - ectopic pregnancy can be fatal if missed
Using CT in first trimester - teratogenic radiation exposure when ultrasound is superior 2
Delaying tranexamic acid - most effective when given within 3 hours of bleeding onset 4
Assuming postmenopausal bleeding is benign - endometrial cancer must be excluded 5
Inserting LNG-IUS during acute bleeding - should be delayed until hemodynamically stable and bleeding controlled 6
Underestimating blood loss - clinical assessment often underestimates actual volume; use objective measures when possible
Failing to transition to maintenance therapy - acute control without long-term plan leads to recurrence 1, 6